TABLE 1.

Representative antiviral siRNA data from Chinese patent CN101173275, CN1648249, and US patent US20050004063

Patent	siRNA	Sequence	Target region/gene
CN101173275	siRNA‐M1	5′‐GGGUGACUGGCGGGAUUGCGAU‐3	460‐480 bp
	siRNA‐M2	5′‐GGGCGCUGUGACAUUAAGGAC‐3
CN1648249	8*	5′‐CGUCGCAGCGUGUAGGCACUA‐3′	M protein gene
	51*	5′‐AACGGUUUACGUCUACUCGCA‐3′	N protein gene
	56*	5′‐AACGUACUGCCACAAAACAGC‐3′	E protein gene
US20050004063	SARSi‐1	5′‐GUGAACUCACUCGUGAGCUCTT‐3′	512‐531 bp of replicase A1 region
	SARSi‐2	5′‐GUACCCUCUUGAUUGCAUCTT‐3′	586‐604 bp of replicase A1 region
	SARSi‐3	5′‐GAGUCGAAGAGAGGUGUCUTT‐3′	916‐934 bp of replicase A1 region
	SARSi‐4	5′‐GCACUUGUCUACCUUGAUGTT‐3′	1194‐1213 of replicase A1 region
	SARSi‐5	5′‐CCUCCAGAUGAGGAAGAAGTT‐3′	3028‐3046 bp of replicase A region
	SARSi‐6	5′‐GGUGUUUCCAUUCCAUGUGTT‐3′	5024‐5042 bp of replicase A region